Skip to main content
SpringerLink
Log in

Dyslipidemia, chronic kidney disease, atherosclerotic cardiovascular disease, and statins

  • Letter to the Editor
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mathew RO, Rosenson RS, Lyubarova R, Chaudhry R, Costa SP, Bangalore S, Sidhu MS. Concepts and controversies: Lipid management in patients with chronic kidney disease. Cardiovasc Drugs Ther. 2021;35(3):479–89.

    Article  CAS  Google Scholar 

  2. Vega GL, Wang J, Grundy SM. Chronic kidney disease and statin eligibility. J Clin Lipidol. 2021;15(1):173–80.

    Article  Google Scholar 

  3. Zhao L, Li S, Gao Y. Efficacy of statins on renal function in patients with chronic kidney disease: a systematic review and meta-analysis. Ren Fail. 2021;43(1):718–28.

    Article  CAS  Google Scholar 

  4. Sandfort V, Lai S, Ahlman MA, Mallek M, Liu S, Sibley CT, Turkbey EB, Lima JA, Bluemke DA. Obesity is associated with progression of atherosclerosis during statin treatment. J Am Heart Assoc. 2016;5(7):e003621.

    Article  Google Scholar 

  5. Heine GH, Eller K, Stadler JT, Rogacev KS, Marsche G. Lipid-modifying therapy in chronic kidney disease: Pathophysiological and clinical considerations. Pharmacol Ther. 2020;207:107459.

    Article  CAS  Google Scholar 

  6. Esmeijer K, Dekkers OM, de Fijter JW, Dekker FW, Hoogeveen EK. Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis. Sci Rep. 2019;9(1):16632.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hygiene and Public Health, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo, 113-8602, Japan

    Tomoyuki Kawada

Authors
  1. Tomoyuki Kawada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomoyuki Kawada.

Ethics declarations

Conflict of interest

None declared.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kawada, T. Dyslipidemia, chronic kidney disease, atherosclerotic cardiovascular disease, and statins. Cardiovasc Drugs Ther 36, 569–570 (2022). https://doi.org/10.1007/s10557-021-07284-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-021-07284-x

Search

Navigation